MedPath

The Impact of a Topical Vasodilating Cream on Female Sexual Experience

Conditions
Female Sexual Dysfunction
Registration Number
NCT01078077
Lead Sponsor
Michael Pelekanos MD
Brief Summary

The purpose of this study is to determine if a topical vasodilating cream will improve female sexual experience.

Detailed Description

To determine in a placebo controlled double blinded study whether a topically applied vasodilating cream will improve the female sexual response as measured by a standard female sexual dysfunction questionnaire

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
200
Inclusion Criteria
  • Healthy females ages 25 to sixty sexually active
Exclusion Criteria
  • Neurologic disease, on SSRI's,advanced diabetes, non sexually active, mentally incompetent

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (3)

East Suburban Obgyn

πŸ‡ΊπŸ‡Έ

Monroeville, Pennsylvania, United States

West Penn Allegheny Health Center

πŸ‡ΊπŸ‡Έ

Monroeville, Pennsylvania, United States

West Penn Hospital Forbes Campus

πŸ‡ΊπŸ‡Έ

Monroeville, Pennsylvania, United States

East Suburban Obgyn
πŸ‡ΊπŸ‡ΈMonroeville, Pennsylvania, United States
Michael J Pelekanos, MD
Principal Investigator
Guy Stoffman, MD
Contact
412 3706313
guystof@aol.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.